Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Investigational New Drugs|January 1, 1997
Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group studyJ G Wall, J K Benedetti, M A O'Rourke, et al.American Journal of Clinical Oncology|April 25, 2001
Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancerM Meyer, E Jeong, B Bolinger, et al.Cancer|December 1, 1988
Cisplatin and mitoguazone. An induction chemotherapy regimen in advanced head and neck cancerA A Forastiere, D J Perry, G T Wolf, et al.Investigational New Drugs|July 1, 1992
Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group StudyA Allen, M Wolf, E D Crawford, et al.Cancer|March 15, 1981
Methotrexate: an active drug in bladder cancerR B Natale, A Yagoda, R C Watson, et al.Cancer|November 1, 1979
A critical analysis of response criteria in patients with prostatic cancer treated with cis-diamminedichloride platinum IIA Yagoda, R C Watson, R B Natale, et al.Investigational New Drugs|January 1, 1995
Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group studyM Slavik, P Y Liu, E H Kraut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neckA A Forastiere, R B Natale, B J Takasugi, et al.International Journal of Cancer|February 15, 1994
Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinomaJ H Moore, E J Lesser, D H Erdody, et al.Cancer|September 1, 1995
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group studyJ L Berenberg, C Tangen, J S Macdonald, et al.Pageof 7